[Therapeutic de-escalation strategies in the use of anti-PD-1 and anti-PD-L1: Dose, frequency, and duration].
- DOI
- 10.1016/j.bulcan.2026.01.027
- Published
- 2026 Jun
- Container
- Bulletin du cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bulcan.2026.01.027,
title = {[Therapeutic de-escalation strategies in the use of anti-PD-1 and anti-PD-L1: Dose, frequency, and duration].},
author = {Philipps L and Mas L and Samaille T and André T and Blanchet B and Cohen R},
year = {2026},
journal = {Bulletin du cancer},
doi = {10.1016/j.bulcan.2026.01.027},
url = {https://doi.org/10.1016/j.bulcan.2026.01.027}
}RIS
TY - JOUR TI - [Therapeutic de-escalation strategies in the use of anti-PD-1 and anti-PD-L1: Dose, frequency, and duration]. AU - Philipps L AU - Mas L AU - Samaille T AU - André T AU - Blanchet B AU - Cohen R PY - 2026 JO - Bulletin du cancer DO - 10.1016/j.bulcan.2026.01.027 UR - https://doi.org/10.1016/j.bulcan.2026.01.027 ER -
APA
L, P., L, M., T, S., T, A., B, B., & R, C. (2026). [Therapeutic de-escalation strategies in the use of anti-PD-1 and anti-PD-L1: Dose, frequency, and duration].. Bulletin du cancer. https://doi.org/10.1016/j.bulcan.2026.01.027
Source records
- pubmed · retrieved 2026-09-26T17:32:20.166Z